9 results match your criteria: "Saint Bartholomew's and the Royal London School of Medicine and Dentistry[Affiliation]"
Inflammopharmacology
May 2007
Experimental Pathology Group, William Harvey Research Institute, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, Charterhouse Square, London, EC1M 6BQ, UK.
Articular cartilage injury presents a unique therapeutic challenge. As cartilage possesses no blood or nerve supply of its own it has a particular susceptibility to early injury and a poor capacity for self-repair. Treatment options are limited and injury can eventually lead to osteoarthritis.
View Article and Find Full Text PDFAngiogenesis
January 1998
Saint Bartholomew's and the Royal London School of Medicine and Dentistry, Department of Experimental Pathology, Charterhouse Square, London EC1M 6BQ, UK.
Hyaluronan is an essential component of the extracellular matrix and alters the quality of wound healing as well as modulating angiogenesis. It is also used as a topical and i.v.
View Article and Find Full Text PDFBrain Res
November 2000
Neurotransmission Laboratory, Academic Department of Anaesthesia and Intensive Care, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital, Whitechapel, E1 1BB, London, UK.
This study used the peptides omega-conotoxin GVIA, omega-agatoxin IVA and omega-conotoxin MVIIC, singly and in combination, to investigate the relative involvement of N-, P- and Q-type voltage-operated calcium channels in the control of striatal dopamine release. Electrically stimulated dopamine release was measured by fast cyclic voltammetry at carbon fibre microelectrodes in rat striatal slices. The contribution of these channel subtypes was compared in dorsolateral and medial neostriatum for 'regular' (discrete) and 'burst' stimulation modalities.
View Article and Find Full Text PDFRheumatology (Oxford)
September 1999
The William Harvey Research Institute, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, UK.
Eur J Pharmacol
August 1998
Department of Experimental Pathology, William Harvey Research Institute, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, UK.
The anti-inflammatory activity of drugs more selective for cyclooxgenase isoform inhibition (cyclooxygenase 1, cyclooxygenase 2), were compared in rat carrageenin-induced pleurisy. Suppression of inflammation by cyclooxygenase 2-selective inhibitors, NS-398 (N-[-2-cyclohexyloxy]-4-nitrophenyl methanesulphonamide) and nimesulide (4-nitro-2-phenoxy-methanesulfonanilide), and by piroxicam and aspirin, more selective for cyclooxygenase 1, was measured. Piroxicam and aspirin significantly inhibited inflammatory cell influx, exudate and prostaglandin E2 formation, 6 h after carrageenin injection.
View Article and Find Full Text PDFInt J Radiat Biol
September 1998
Department of Radiation Biology, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, UK.
Purpose: To investigate the hypothesis that modulation of the function of activated macrophages is one of the mechanisms of the clinically observed anti-inflammatory and analgesic efficacy of low-dose radiotherapy in the treatment of a variety of painful joint diseases with total doses between 1 and 6 Gy.
Materials And Methods: Metabolic activity, cell proliferation, reproductive integrity, nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by unstimulated or [LPS/gamma-IFN-stimulated macrophages in vitro was investigated at different times after radiation doses ranging from 0.3 Gy to 10 Gy.
Pediatr Res
September 1997
University of London, Department of Child Health, Saint Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College.
Using spectral analysis we have studied changes in the heart rate during periodic thermal stimulation of one foot of infants during quiet sleep. Twenty-two appropriately grown preterm infants were studied in the first 15 d after birth to quantify responses in comparison with previously reported term infants. Babies were stimulated at 0.
View Article and Find Full Text PDFCancer Res
May 1997
Department of Experimental Pathology, Saint Bartholomew's Hospital and the Royal London School of Medicine and Dentistry, United Kingdom.
Topical diclofenac in 2.5% hyaluronan inhibits basal cell carcinoma, actinic keratosis, and murine colon-26 growth in vivo. colon-26 tumor growth was preceded by angiogenesis and reduced apoptotic and mitotic indices.
View Article and Find Full Text PDF